In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pulmonary thromboembolism: diagnostic and treatment strategies for the clinical cardiologist

ESC webinar

20/06/2012 00:00 20/06/2012 00:00 Europe/Paris Pulmonary thromboembolism: diagnostic and treatment strategies for the clinical cardiologist

Access event page

European Society of Cardiology DD/MM/YYYY
Pulmonary Embolism
Pulmonary Circulation
Venous Thromboembolism
Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure

Watch the webinar recording



Stavros V. Konstantinides and Simon Gibbs

Learning objectives

At the end of the webinar, the participant should be able to:

  • Understand the relative importance of disorders and conditions predisposing to venous thromboembolism
  • Determine the clinical probability of acute pulmonary embolism (PE) upon suspicion of the disease
  • Understand the importance of the pretest probability for the accuracy of a diagnostic imaging test
  • Rapidly differentiate between high-risk and non-high-risk PE 
  • Detect an elevated early risk among normotensive (non-high-risk) patients with acute PE
  • Identify the candidates for immediate “advanced” therapy (thrombolysis, surgical embolectomy, interventional treatment, inferior vena cava filter placement)
  • Optimise treatment with vitamin K antagonists to reach and maintain a therapeutic International Normalized Ratio (INR)
  • Dissect the potential benefits from the hazards/uncertainties of new oral anticoagulants
  • Tailor the regimen and duration of anticoagulation to the individual patient’s needs

Course Content

  • Pathophysiology of acute PE- Diagnosis of PE (clinical prediction rules and imaging tests)
  • Initial and advanced risk stratification 
  • Severity-adjusted diagnostic and treatment strategies
  • Advances in anticoagulation with vitamin K antagonists
  • New oral anticoagulants in the treatment and prophylaxis of venous thromboembolism
  • Recurrence risk and optimal duration of anticoagulation
  • Risk of chronic thromboembolic pulmonary hypertension (CTEPH)

Key references

ESC Guidelines on Diagnosis and Treatment of Pulmonary Embolism (Torbicki et al.)